ATE253889T1 - Mittel und verfahren zur prävention und behandlung von immediaten überempfindlichkeitsreaktionen der haut - Google Patents

Mittel und verfahren zur prävention und behandlung von immediaten überempfindlichkeitsreaktionen der haut

Info

Publication number
ATE253889T1
ATE253889T1 AT96909848T AT96909848T ATE253889T1 AT E253889 T1 ATE253889 T1 AT E253889T1 AT 96909848 T AT96909848 T AT 96909848T AT 96909848 T AT96909848 T AT 96909848T AT E253889 T1 ATE253889 T1 AT E253889T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
composition
hypersensitivity reactions
skin
Prior art date
Application number
AT96909848T
Other languages
English (en)
Inventor
Emmett Clemente
Robert W Mendes
Aloysius O Anaebonam
Mumtaz Ahmed
Original Assignee
Ascent Pediatrics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascent Pediatrics Inc filed Critical Ascent Pediatrics Inc
Application granted granted Critical
Publication of ATE253889T1 publication Critical patent/ATE253889T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
AT96909848T 1995-04-03 1996-03-25 Mittel und verfahren zur prävention und behandlung von immediaten überempfindlichkeitsreaktionen der haut ATE253889T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/415,722 US5532270A (en) 1995-04-03 1995-04-03 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions
PCT/US1996/003966 WO1996031193A1 (en) 1995-04-03 1996-03-25 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions

Publications (1)

Publication Number Publication Date
ATE253889T1 true ATE253889T1 (de) 2003-11-15

Family

ID=23646920

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909848T ATE253889T1 (de) 1995-04-03 1996-03-25 Mittel und verfahren zur prävention und behandlung von immediaten überempfindlichkeitsreaktionen der haut

Country Status (9)

Country Link
US (3) US5532270A (de)
EP (1) EP0818987B1 (de)
AT (1) ATE253889T1 (de)
AU (1) AU720338B2 (de)
CA (1) CA2216386C (de)
DE (1) DE69630684T2 (de)
ES (1) ES2210353T3 (de)
WO (1) WO1996031193A1 (de)
ZA (1) ZA962635B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532270A (en) * 1995-04-03 1996-07-02 Ascent Pharmaceuticals, Inc. Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions
US6150400A (en) * 1997-06-30 2000-11-21 Presutti Laboratories Method for treating vulvar vestibulitis
US6379684B1 (en) * 2001-05-02 2002-04-30 Alphamed Pharaceutical Corp. Cosmetic compositions containing cromolyn compounds for revitalizing the skin
US7147860B2 (en) * 2001-11-28 2006-12-12 Centum Research, Llc Composition for symptomatic relief of vaginitis
US6818668B2 (en) 2002-04-12 2004-11-16 Biotest Laboratories, Llc 5-alkyl-7-alkylcarbonate-isoflavone ester and related method
US8569093B2 (en) * 2006-03-15 2013-10-29 Micron Technology, Inc. Microelectronic devices and methods for manufacturing microelectronic devices

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK38179A (en) * 1973-12-19 1979-06-22 Fisons Ltd Topical compositions
JPH03148208A (ja) * 1989-11-02 1991-06-25 Mikimoto Seiyaku Kk 皮膚外用剤
GB9214390D0 (en) * 1992-07-07 1992-08-19 Fisons Plc Formulations
DE4327089A1 (de) * 1993-08-12 1995-02-16 Roshdy Ismail Mittel zur Behandlung von allergischen Erkrankungen der Atemwege
US5532270A (en) * 1995-04-03 1996-07-02 Ascent Pharmaceuticals, Inc. Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions

Also Published As

Publication number Publication date
US5532270A (en) 1996-07-02
ES2210353T3 (es) 2004-07-01
CA2216386A1 (en) 1996-10-10
AU720338B2 (en) 2000-05-25
CA2216386C (en) 2002-05-28
AU5322096A (en) 1996-10-23
EP0818987A1 (de) 1998-01-21
EP0818987A4 (de) 2000-05-03
EP0818987B1 (de) 2003-11-12
WO1996031193A1 (en) 1996-10-10
US5684037A (en) 1997-11-04
DE69630684D1 (de) 2003-12-18
ZA962635B (en) 1996-10-07
US5684038A (en) 1997-11-04
MX9707478A (es) 1998-06-28
DE69630684T2 (de) 2004-09-23

Similar Documents

Publication Publication Date Title
US3549770A (en) Therapeutic administration of effective amounts of dimethyl sulfoxide to human and animal subjects
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
PT1326613E (pt) Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos
ATE181235T1 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
ATE170077T1 (de) Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'- halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff
DE69914084D1 (de) Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
ATE99932T1 (de) Verwendung von pyrrolicloncarbonsaeurealkylestern zur herstellung eines arzneimittels zur behandlung von ichtyosis.
DE69713620D1 (de) Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DE69400353D1 (de) Schlankmachende Zusammensetzung
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
DE59002748D1 (de) Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
KR101782671B1 (ko) 피부 질환을 치료하는 방법
ATE253889T1 (de) Mittel und verfahren zur prävention und behandlung von immediaten überempfindlichkeitsreaktionen der haut
ATE230609T1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE198418T1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
DE60306503D1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
BG105924A (en) Composition for the treatment of psoriasis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties